Drug recall · April 12, 2023
Dodex Injectable Cyanocobalamin Injection recall
Why: Sub-potent drug: assay test result below specifications at 9-month timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.
- Lots / codes
Lot #: R2200394 Exp. 03/2024
- Quantity
- 4574 cartons
- Company
- Accord Healthcare, Inc., Durham, NC
- Distribution
- Nationwide in the USA.
- Initiated
- March 29, 2023 · Voluntary: Firm initiated
- Classified
- April 6, 2023
- Reported
- April 12, 2023
- Ended
- March 19, 2025
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.